|
|
Volumn 92, Issue 12, 2001, Pages 2993-2998
|
|
Chemotherapy with an every-2-week regimen of gemcitabine and paclitaxel in patients with transitional cell carcinoma who have received prior cisplatin-based therapy
a
|
|
Author keywords
Gemcitabine; Paclitaxel; Recurrent transitional cell carcinoma; Second line chemotherapy
|
|
Indexed keywords
CISPLATIN;
DOXORUBICIN;
GEMCITABINE;
GRANULOCYTE COLONY STIMULATING FACTOR;
METHOTREXATE;
PACLITAXEL;
VINBLASTINE;
ADULT;
AGED;
ANEMIA;
ARTICLE;
CANCER ADJUVANT THERAPY;
CANCER CHEMOTHERAPY;
CANCER REGRESSION;
CANCER SURVIVAL;
CLINICAL ARTICLE;
DRUG EFFICACY;
DRUG TOLERABILITY;
FEBRILE NEUTROPENIA;
FEMALE;
HUMAN;
MALE;
OUTPATIENT CARE;
PRIORITY JOURNAL;
THROMBOCYTOPENIA;
TRANSITIONAL CELL CARCINOMA;
TREATMENT FAILURE;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, TRANSITIONAL CELL;
CISPLATIN;
DEOXYCYTIDINE;
DOXORUBICIN;
DRUG ADMINISTRATION SCHEDULE;
DRUG RESISTANCE, NEOPLASM;
FEMALE;
GRANULOCYTE COLONY-STIMULATING FACTOR;
HUMANS;
INFUSIONS, INTRAVENOUS;
MALE;
METHOTREXATE;
MIDDLE AGED;
NEOPLASM RECURRENCE, LOCAL;
PACLITAXEL;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
URINARY BLADDER NEOPLASMS;
VINBLASTINE;
|
|
EID: 0035892761
PISSN: 0008543X
EISSN: None
Source Type: Journal
DOI: 10.1002/1097-0142(20011215)92:12<2993::AID-CNCR10108>3.0.CO;2-2 Document Type: Article |
|
Times cited : (206)
|
|
References (21)
|
